109 related articles for article (PubMed ID: 27934878)
21. Pathological and Molecular Diagnosis of Uveal Melanoma.
Păsărică MA; Curcă PF; Dragosloveanu CDM; Grigorescu AC; Nisipașu CI
Diagnostics (Basel); 2024 May; 14(9):. PubMed ID: 38732371
[TBL] [Abstract][Full Text] [Related]
22. Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives.
Croce M; Ferrini S; Pfeffer U; Gangemi R
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31216772
[TBL] [Abstract][Full Text] [Related]
23. GNAQ/GNA11 Mosaicism Is Associated with Abnormal Serum Calcium Indices and Microvascular Neurocalcification.
Knöpfel N; Zecchin D; Richardson H; Polubothu S; Barberan-Martin S; Cullup T; Gholam K; Heales S; Krywawych S; López-Balboa P; Muwanga-Nanyonjo N; Ogunbiyi O; Puvirajasinghe C; Solman L; Swarbrick K; Syed SB; Tahir Z; Tisdall MM; Allgrove J; Chesover AD; Aylett SE; Jacques TS; Hannan FM; Löbel U; Semple RK; Thakker RV; Kinsler VA
J Invest Dermatol; 2024 Apr; 144(4):820-832.e9. PubMed ID: 37802294
[TBL] [Abstract][Full Text] [Related]
24. Characterization of Patient-Derived GNAQ Mutated Endothelial Cells from Capillary Malformations.
Langbroek GB; Stor MLE; Janssen V; de Haan A; Horbach SER; Graupera M; van Noesel CJM; van der Horst CMAM; Wolkerstorfer A; Huveneers S
J Invest Dermatol; 2024 Jun; 144(6):1378-1388.e1. PubMed ID: 38013159
[TBL] [Abstract][Full Text] [Related]
25. MEK inhibition reduced vascular tumor growth and coagulopathy in a mouse model with hyperactive GNAQ.
Schrenk S; Bischoff LJ; Goines J; Cai Y; Vemaraju S; Odaka Y; Good SR; Palumbo JS; Szabo S; Reynaud D; Van Raamsdonk CD; Lang RA; Boscolo E
Nat Commun; 2023 Apr; 14(1):1929. PubMed ID: 37024491
[TBL] [Abstract][Full Text] [Related]
26. Update on
Larribère L; Utikal J
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32532044
[TBL] [Abstract][Full Text] [Related]
27. Uveal melanoma: progress in molecular biology and therapeutics.
Li Y; Shi J; Yang J; Ge S; Zhang J; Jia R; Fan X
Ther Adv Med Oncol; 2020; 12():1758835920965852. PubMed ID: 33149769
[TBL] [Abstract][Full Text] [Related]
28. Detection of the Uveal Melanoma-Associated Mutation
Escalona-Noguero C; Alarcón-Iniesta H; López-Valls M; Del Carpio LP; Piulats JM; Somoza Á; Sot B
Anal Chem; 2023 Nov; 95(45):16692-16700. PubMed ID: 37921444
[TBL] [Abstract][Full Text] [Related]
29. Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma.
Li Z; Zhang X; Xue W; Zhang Y; Li C; Song Y; Mei M; Lu L; Wang Y; Zhou Z; Jin M; Bian Y; Zhang L; Wang X; Li L; Li X; Fu X; Sun Z; Wu J; Nan F; Chang Y; Yan J; Yu H; Feng X; Wang G; Zhang D; Fu X; Zhang Y; Young KH; Li W; Zhang M
Nat Commun; 2019 Sep; 10(1):4209. PubMed ID: 31527657
[TBL] [Abstract][Full Text] [Related]
30. Molecular Frontiers in Melanoma: Pathogenesis, Diagnosis, and Therapeutic Advances.
Kim HJ; Kim YH
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474231
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant treatment of melanoma.
Moreno Nogueira JA; Valero Arbizu M; Pérez Temprano R
ISRN Dermatol; 2013; 2013():545631. PubMed ID: 23476798
[TBL] [Abstract][Full Text] [Related]
32. Neuronal activation of G
Stevenson ME; Bieri G; Kaletsky R; St Ange J; Remesal L; Pratt KJB; Zhou S; Weng Y; Murphy CT; Villeda SA
Cell Rep; 2023 Sep; 42(9):113151. PubMed ID: 37713310
[TBL] [Abstract][Full Text] [Related]
33. Eruptive blue nevi of the scalp mimicking melanoma metastases.
Li Pomi F; Macca L; Vaccaro M; Lentini M; Borgia F
Ital J Dermatol Venerol; 2024 Jun; ():. PubMed ID: 38884532
[No Abstract] [Full Text] [Related]
34. MAPK-Activating Gene Fusions in Congenital Nevi.
Flesher JL; Fisher DE
J Invest Dermatol; 2024 Mar; 144(3):446-448. PubMed ID: 37978981
[No Abstract] [Full Text] [Related]
35. Sporadic melanotic schwannoma with overlapping features of melanocytoma bearing a GNA11 mutation in an adolescent girl.
Tatsi C; Bacopoulou F; Lyssikatos C; Belyavskaya E; Faucz FR; Stratakis CA
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 28012237
[TBL] [Abstract][Full Text] [Related]
36. Direct evidence that the GPCR CysLTR2 mutant causative of uveal melanoma is constitutively active with highly biased signaling.
Ceraudo E; Horioka M; Mattheisen JM; Hitchman TD; Moore AR; Kazmi MA; Chi P; Chen Y; Sakmar TP; Huber T
J Biol Chem; 2021; 296():100163. PubMed ID: 33288675
[TBL] [Abstract][Full Text] [Related]
37. CYSLTR2-mutant Cutaneous Melanocytic Neoplasms Frequently Simulate "Pigmented Epithelioid Melanocytoma," Expanding the Morphologic Spectrum of Blue Tumors: A Clinicopathologic Study of 7 Cases.
Goto K; Pissaloux D; Paindavoine S; Tirode F; de la Fouchardière A
Am J Surg Pathol; 2019 Oct; 43(10):1368-1376. PubMed ID: 31162285
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity and molecular landscape of melanoma: implications for targeted therapy.
Beigi YZ; Lanjanian H; Fayazi R; Salimi M; Hoseyni BHM; Noroozizadeh MH; Masoudi-Nejad A
Mol Biomed; 2024 May; 5(1):17. PubMed ID: 38724687
[TBL] [Abstract][Full Text] [Related]
39. Diagnosing Cutaneous Melanocytic Tumors in the Molecular Era: Updates and Review of Literature.
Huang C; Lau TW; Smoller BR
Dermatopathology (Basel); 2024 Jan; 11(1):26-51. PubMed ID: 38247727
[TBL] [Abstract][Full Text] [Related]
40. Genetics and RNA Regulation of Uveal Melanoma.
Barbagallo C; Stella M; Broggi G; Russo A; Caltabiano R; Ragusa M
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
